Early Clinical Remission Is a Predictor of Long-Term Remission with the Use of Vedolizumab for Ulcerative Colitis.
Haga K, Shibuya T, Osada T, Sato S, Fukuo Y, Kobayashi O, Yamada T, Asaoka D, Ito K, Nomura K, Haraikawa M, Nomura O, Fukushima H, Murakami T, Ishikawa D, Hojo M, Nagahara A.
Haga K, et al. Among authors: nagahara a.
Biomedicines. 2022 Oct 9;10(10):2526. doi: 10.3390/biomedicines10102526.
Biomedicines. 2022.
PMID: 36289788
Free PMC article.